Dr. Jan M. Lundberg, Former Head of RandD at AstraZeneca and Eli Lilly has Joined Betagenon's Board of Directors

Dr. Jan M Lundberg brings extensive industrial competence to Betagenon STOCKHOLM, Jan. 3, 2019 -- (Healthcare Sales & Marketing Network) -- "Jan's executive industrial experience as head of R&D at two major pharmaceutical companies, and his involv... Biopharmaceuticals, Personnel Betagenon
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news